Skip Navigation


Rheumatology Advance Access originally published online on April 10, 2008
Rheumatology 2008 47(6):894-896; doi:10.1093/rheumatology/ken084
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow All Versions of this Article:
47/6/894    most recent
ken084v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Alexánderson, E.
Right arrow Articles by Amigo, M.-C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Alexánderson, E.
Right arrow Articles by Amigo, M.-C.
Related Collections
Right arrow Systemic Lupus Erythematosus and Autoimmunity
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author 2008. Published by Oxford University Press on behalf of the British Society for Rheumatology. All rights reserved. For Permissions, please email: journals.permissions@oxfordjournals.org

Myocardial ischaemia in patients with primary APS: a 13N-ammonia PET assessment

E. Alexánderson1,2, A. Gómez-León1, A. Vargas1, J. L. Romero2, C. Sierra Fernández2, M. Rodriguez Valero2, L. García-Rojas2, A. Meave1 and M.-C. Amigo1

1Instituto Nacional de Cardiología Ignacio Chávez and 2PET-Ciclotrón Unit, UNAM (PET-UNAM), Mexico City, México.

Correspondence to: E. Alexánderson, Juan Badiano No. 1. Colonia Sección XVI CP 14080, México D.F. E-mail: alexanderick{at}yahoo.com


  Abstract

Objective. Evaluate the presence and severity of myocardial ischaemia in a population of asymptomatic patients with primary APS (PAPS) using 13N-ammonia PET.

Methods. We studied 36 patients, 18 with a diagnosis of PAPS and 18 healthy volunteers. All patients underwent a two-phase (rest–stress) 13N-ammonia PET. Myocardial perfusion images were acquired and then analysed by two experts in the field.

Results. We found ischaemia in 7/18 asymptomatic PAPS patients (38.8%). The anterolateral wall was the most commonly affected cardiac territory [5/7 PAPS patients (71.4%)]. In a severity analysis, we found that five patients (71.4%) had mild ischaemia, one patient (14.2%) had moderate ischaemia and another one (14.2%) had severe defects. All the healthy volunteers studied showed normal myocardial perfusion images.

Conclusion. An important proportion of PAPS patients, even when asymptomatic, showed myocardial perfusion defects assessed with PET. Most of the ischaemic patients had mild defects and the anterolateral wall was the territory mainly affected.

KEY WORDS: Primary anti-phospholipid syndrome, Ischaemia, Positron emission tomography, 13N-ammonia, Thrombosis, Coronary disease, Ischaemic heart disease, Autoimmune diseases, Heart, Cardiovascular imaging

Submitted 20 July 2007; revised version accepted 4 February 2008.
Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?




Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.